Page last updated: 2024-09-03

3-tyr-octreotide and Adenoma, Prolactin-Secreting, Pituitary

3-tyr-octreotide has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kato, Y1
den Holder, F; Hofland, LJ; Koper, JW; Lamberts, SW; van Koetsveld, PM1

Reviews

1 review(s) available for 3-tyr-octreotide and Adenoma, Prolactin-Secreting, Pituitary

ArticleYear
[Drug therapy of pituitary tumors].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1991, Mar-10, Volume: 80, Issue:3

    Topics: Bromocriptine; Cushing Syndrome; Cyproheptadine; Female; Humans; Male; Metyrapone; Octreotide; Pituitary Neoplasms; Prolactinoma

1991

Other Studies

1 other study(ies) available for 3-tyr-octreotide and Adenoma, Prolactin-Secreting, Pituitary

ArticleYear
Desensitization and resensitization of rat pituitary tumor cells in long-term culture to the effects of the somatostatin analogue SMS 201-995 on cell growth and prolactin secretion.
    Cancer research, 1990, Oct-01, Volume: 50, Issue:19

    Topics: Animals; Cell Division; Dose-Response Relationship, Drug; Drug Tolerance; Female; Octreotide; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Receptors, Neurotransmitter; Receptors, Somatostatin; Time Factors; Tumor Cells, Cultured

1990